Treatment of Plantar Warts

Phase 3

• Conditions: Plantar Wart
• Interventions: Drug: Topical 30%Potassium hydroxide solution; Drug: Topical 45% hydrogen peroxide solution

• Registration Number: NCT05198180
• Lead Sponsor: Sohag University

Brief Summary

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-12-26
• Status Verified: 2022-01
• Study First Submitted QC: 2022-01-15
• Last Update Submitted: 2022-01-15
• Study First Posted: 2022-01-20
• Last Update Posted: 2022-01-20
• Study Start: 2022-02
• Primary Completion: 2022-06
• Study Completion: 2022-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• confirmed diagnosis by clinical and dermoscopic examination of plantar warts

Exclusion Criteria

• history of hypersensitivity to any component used in this study
• pregnancy and breastfeeding
• patients who receive immune suppressive therapy
• patients who received any wart treatments during the last 2 months before enrollent in the study
• patients who refused participation in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Potassium hydroxide group	Topical 30%Potassium hydroxide solution	Patients with plantar warts will apply topical 30% potassium hydroxide solutions on warts
Hydrogen peroxide group	Topical 45% hydrogen peroxide solution	Patients with plantar warts will use topical 45% hydrogen peroxide solution on warts

Primary Outcome Measures

Name	Time	Method
Change in the size of the plantar warts	12 weeks after end of treatment	Decrease in the size of warts measured by a ruler

Trial Locations

Locations (1)

Sohag faculty of medicine; 🇪🇬 Sohag, Egypt